OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

The founder of Dynamisk Helse, Ann-Kristin Johansen, worked for several years as a nurse in hospitals and elderly care organizations. She experienced first-hand the lack of proper training which sometimes led to negative incidences for the patients as well as the staff. Sometimes the result had devastating outcomes, with a person's life at risk. Ann-Kristin felt sad and angry and felt the need to personally take action. This resulted in the foundation of Dynamisk Helse AS in 2011. We believe in small drops of theoretical and practical case-specific training, tailored naturally into our daily work. As there was no software platform available we felt was appropriate, we made it ourselves. Starting with making the “Drops first aid” app, which received fantastic feedback around the globe. (still available in Appstore) After this first test of response, we continued developing our own philosophy into a software platform that exceeds normal standards today. With limitless scalability and access on all digital surfaces. The number of elderly and inhabitants with chronic diseases, is going to double within ten years, resulting in dramatic demand for qualified healthcare workers. The leaders in healthcare struggle with high turnover and a shortage of both time and recourses to train the temps. Drops smartphone solution gives access to short and precise information about what to do when they need it, by scanning a QR code. Our Drops Skill aid system enables healthcare leaders to support staff in day-to-day tasks. We save costs for our customers, and provide a better service for patients, while we support care workers in building their skills and confidence.

Halify AS operates on markets within the field of urban spatial area management, with a specific focus on Intelligent Transport Systems (ITS) and urban mobility. We have supplied solutions for Horizon2020-funded projects (VICINITY, CrossMove, BIG IoT), and received support from the Research Council of Norway on projects like Komét and Sparkling, and cooperated with the NCE environment in Horten and Oslo. We are active within several consortiums and part of the Smart Cities Norway network, the ENIT network, and ITS Arena. We have developed solutions for calculating and visualizing the environmental impact made by the transport industry on Norwegian municipalities, and take pride in visualizing difficult concepts and results in a way that is easy to convey.

A specialist travel company focusing on tours and voyages to the Nordic & Arctic regions, Scandinavia, Greenland, Iceland, Russia, Mongolia and the Baltics, with offices in Norway and Australia. 50 Degrees North is a niche, independently owned, specialist travel company that aims to give you a little more than just a holiday. We specialise regionally, as we believe it is not possible to be good at everything. We also focus on offering the most enriching style of travel. Not necessarily cheap, but rewarding, full of real-life experiences and with incredible value for money. If you are just as excited about Nordic and Arctic travel as we are, join our fast-growing international team here in Norway!

ZEN OCEANS is a startup developing fully electric, autonomous-ready ships to affordably decarbonize ocean transport. We will think big and nudge the market for fully electric ships from 0 to 1. To fund our vision, we will develop products that in themselves can scale into large revenue-generating operations; among them maritime batteries (ZENERGY) and autonomy solutions (OCEANEYE). The future of ocean shipping is simple, safe, and sustainable - the frictionless fabric of global trade. Consequently, we consider the argument for electric and autonomous ships to be very strong. We envision a fleet of electric ships deployed at scale, coordinated by an intelligent network for the efficient movement of goods. The future starts now. Maritime batteries: We develop safe and low-cost maritime batteries for large energy systems. Type approval by DNV is ongoing. Fully electric ships: We develop energy- and cost-effective electric ship concepts for short sea trade and more. If you want to learn more, please reach out to us!

NORIGIN MEDIA is a TV Everywhere company, which enables multi-screen and OTT services for carriers, broadcasters, and content owners. The Scandinavian company offers a complete multi-screen application suite and a Live TV hosting headend capacity as primary products. NORIGIN MEDIA is reinventing how people watch TV. Join the technical revolution on how people will consume TV content in the years to come. You will architect and develop user experiences that will reach millions of TV users on Smartphones, Tablets, PCs, Connected TV, and Game Consoles.

Cleanera will offer a easier solution to our most un-liked chores, which is laundry! We will offer an integrated platform where you can decide upon subscription or single use options, of course cancel anytime policy! So how does this work? Well we will pick-up and deliver your laundry and with easy subscription where you save 3+ hours weekly of laundry work! Note only work you have to do is to put it back in the closet, something we cannot do 😜 Cleanera will solve an inertia industry by solving the logistical problems and create a new innovative approach on how customers will do laundry in the future! That is through Cleanera! Does this idea find your interest? please contact us for more info or thinking about joining us!

Bringing Scandinavian taste and culture to the world. We are a start-up that sends curated or custom snack boxes to the USA, UK, Australia and Canada. Right now, we have a one-off shop on our website, but we are going to be moving to a subscription model where every two months you get an excellent pack of snacks, chocolates, chips, healthy snacks from Norway and other countries in Scandinavia.

Joymo is a streaming platform that makes it easy for any sport club, federation, league and event, anywhere in the world, to broadcast their valuable content to fans across the globe. Through innovation in technology, broadcasting, AI and automation, Joymo enables the creation of video content from any level in sport and delivers that content to fans, athletes, coaches, referees and scouts through an innovative and exciting platform. Founded by experts from the Scandinavian broadcasting world, Joymo is a movement created to engage fans, develop athletes, and inspire sport.

Aquaai is a marine robotics company that builds affordable robotic fish platforms or specialized fishlike Autonomous Underwater Vehicles (AUV) to collect and deliver real-time visual and environmental data that is accessible on an AI powered online dashboard for multiple industries. We currently service Norwegian sustainable salmon farms near the Arctic Circle.

SammeVei is a tech startup that rolled out 2 mobility apps in the past 4 years: SammeVei; the leading ridesharing app in Norway for the sustainable urban commuting and Pick App; the revolutionary home delivery app for anything anytime! Our vision is backed by the star investors and innovation grant. We believe in on-demand mobility in urban transportation; both in the movement of people and goods.

We are a company that is in the development of a new way of telling stories. We're creating a platform where it's possible to expand the narrative of a story from the main screen (e.g your TV) to a second screen, by using keyframe triggers and secondary screen content delivery. We're currently in a prototype aiming for MVP as the next step.

As a groundbreaking startup company, Virtual Nordic connects with various companies and operators worldwide. This provides important and valuable access to both knowledge and the ability to promote XR technology. Our primary field areas are within important public offerings such as health and educational services.

Evetro develops a digital application to help teams enhance collaboration and find smarter ways to work. We specialize in Retrospectives which is a well known method for continuous improvement. The purpose is to identify opportunities to improve and to reduce wasted time. We want employees to have a safe and natural arena where they can share ideas, adapt to changes and explore improvement opportunities.